Yizhen Guo
Biochemistry, Genetics and Molecular Biology · The Ohio State University
Publications
44
Citations
1,014
Est. group size
~10
Recurring co-author estimate
Active years
37
Publishing since 1990
Yizhen Guo's research focuses on cancer cell metabolism, particularly how tumor cells such as non-small cell lung cancer rewire glucose and energy production pathways to survive and resist drugs like osimertinib. The work explores enzymes involved in this metabolic rewiring (such as hexokinase 2, pyruvate dehydrogenase kinase, and lactate dehydrogenase) as potential drug targets, alongside related projects on nanoparticle-based and natural-compound (e.g., ginsenoside) drug delivery systems for cancer therapy. This research would suit students interested in cancer biochemistry, drug resistance mechanisms, and translational pharmacology.
Publication output has grown over the past decade, rising from just a few papers per year in 2017-2021 to a peak of 9 in 2023, though it has tapered off in 2024-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Targeting Metabolic Vulnerabilities Reveals Hexokinase 2 as a Key Mediator of Resistance to Osimertinib in Non-Small Cell Lung Cancer Models
ACS Pharmacology & Translational Science · 2025
- Feasibility and Target AUC Accuracy of Personalized High Dose Melphalan in Myeloma
Blood · 2024
- Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
Cancer Letters · 2023
- Epigallocatechin gallate circumvents drug‐induced resistance in non‐small‐cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis
Phytotherapy Research · 2023
- Dichloroacetophenone biphenylsulfone ethers as anticancer pyruvate dehydrogenase kinase inhibitors in non-small cell lung cancer models
Chemico-Biological Interactions · 2023
- Combined inhibition of pyruvate dehydrogenase kinase 1 and hexokinase 2 induces apoptsis in non-small cell lung cancer cell models
Experimental Cell Research · 2023
- Cytosolic malic enzyme and glucose‐6‐phosphate dehydrogenase modulate redox balance in <scp>NSCLC</scp> with acquired drug resistance
FEBS Journal · 2023
- Targeting glucose metabolism to develop anticancer treatments and therapeutic patents
Expert Opinion on Therapeutic Patents · 2022
- A Mitochondria-Targeted Phenylbutyric Acid Prodrug Confers Drastically Improved Anticancer Activities
Journal of Medicinal Chemistry · 2022
- Investigation of phase equilibria of the Au–Ni–Sn ternary system and interfacial reactions in the Au/Sn/Ni/Cu multilayer couple
Materials Chemistry and Physics · 2022
- Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents
Drug Discovery Today · 2021
- One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy
Nano-Micro Letters · 2020
- Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer
Theranostics · 2019
- In Vitro/In Vivo Metabolism of Ginsenoside Rg5 in Rat Using Ultra-Performance Liquid Chromatography/Quadrupole-Time-of-Flight Mass Spectrometry
Molecules · 2018
- Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles
Theranostics · 2017
- Theranostics×2
- Materials Science and Engineering C×2
- Journal of Molecular Structure×2
- Nano-Micro Letters×1
- Clinical Lung Cancer×1
- Nicholas Denko
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Smita Kumari
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Ioanna Papandreou
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Chaylen Andolino
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Anjali Gupta
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile